FDA Adopts New Labeling Recommendations concerning latex

US regulators have finalized a policy recommending that medical device companies label their products with a specific warning if they are manufactured using natural rubber latex (NRL) proteins. 


Original source

Registration

Register for receiving PharmaAround news, register for PharmAround events.
Continue registration